Original Research
Accepted on 03 Mar 2026
Prediction of Clinically Significant Complication Following Neoadjuvant Chemoimmunotherapy in Resectable Esophageal Cancer: A Dynamic Systemic Inflammatory Biomarker-Based Model
in Cancer Immunity and Immunotherapy